Wafa Asha
@Wafa_Asha
Followers
96
Following
3K
Media
12
Statuses
136
Radiation Oncologist @khcfkhcc. Specializing in breast & sarcoma. Via @clevelandclinic, @Uiowa, @khcfkhcc. RTs ≠ Endorsements 🆕 account. I have a dream!
Joined November 2024
تجرّأنا، عندما أطلقنا جائزة الملك الحسين لأبحاث السرطان، أن نحلمَ بعالمٍ عربيٍّ ذي أثر راسخ في الأبحاث العالمية، وقد تحوّل ذلك الحلم إلى حقيقة بفضل العقول العربية المبدعة. #جائزة_الحسين_لأبحاث_السرطان #الأردن #مركز_الحسين_للسرطان When we launched the King Hussein Cancer Research
11
10
68
Proud of you as always, @sakhrabdulsalam! Congratulations on this well deserved achievement 👏
Honored to receive the International Early Career Investigator Award @AASLDtweets. Grateful for the mentors and collaborators who made this possible. @Wafa_Asha, always showing up with guidance and support. @ObadaEAbabneh, what you taught me still shapes how I work. #TLM2025
0
0
1
New in #practicalRO: American Brachytherapy Society Education Committee Technical Report: A Resident’s Guide to Evaluation of Prostate Low-Dose-Rate Brachytherapy Treatment Plans. #radonc
https://t.co/iA4U4Vx9m4
0
15
39
Patients on SUPREMO had median 14 lymph nodes removed, so PMRT adds little value for pT1-2N1 after ALND. If ALND not done for SLN+, PMRT still indicated since >30% have risk of additional LN+ per AMAROS & SENOMAC. ASCO guidelines summarize nicely:
ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO...
🚨 NEJM SUPREMO Trial (2025): Do all mastectomy pts need chest-wall RT? 🧐 👩🔬 1,607 women with intermediate-risk breast cancer (pT1N1, pT2N1, or pT3NO or stage pT2NO with a histologic grade 3 or LVSI) randomized to: 🟦 Chest-wall RT (40–50 Gy) vs 🟩 No RT 📊 10-yr Results: 💀
6
47
114
Unlike previous post-mastectomy RT trials which included regional nodal irradiation (BC, Danish, etc), SUPREMO primarily tested chest wall RT only. Let’s compare to 4 other studies which found that RNI for LN+ after ALND can reduce DM. 1/
3
42
121
New in #practicalRO: Real World Guide for Delivering Immunotherapy with Radiotherapy. #radonc
https://t.co/IRwvO816Ky
2
33
83
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer https://t.co/g9DBGL14dk
1
19
58
@ESTRO_RT recommendations on preoperative #radiotherapy in #breastcancer: current and future perspectives – Endorsed by @ASTRO_org Just published @RO_GreenJournal
@OncoAlert #OncoAlert #radonc
https://t.co/nF938Gyi4N
thegreenjournal.com
In the multimodal management of breast cancer, the sequence of treatments — surgery, systemic and radiation therapy (RT) — is primarily based on historical and empirical practices. The traditional...
0
7
20
ANNOUNCING: The next #ISRSWebinar📣 “Single Fraction Lung SBRT” 🗓️Tuesday, 25 November 2025, 2PM CET 🥼Gregory Videtic MDCM, FRCPC, FACR, FASTRO Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Director of Thoracic Radiation
1
1
2
Just published @ejsotweets ▶️ Local management of second #breastcancer event after primary breast conserving therapy: The #patient perspective Share Link: https://t.co/rRsrkr9Oiw
#OncoAlert @OncoAlert
https://t.co/es3vHglAlD
0
5
10
"الحياة قد تنقلب بلحظةٍ بمكالمة هاتفية بنتيجة تحاليل بخطوة خاطئة في الشارع بمقابلة شخص بكلمة أو بموقف حيث لا قوّتك، ولا علمك، ولا فهمك، ولا أموالك ستنفعك أمام أي لحظة من هذه اللّحظات لا أحد يعرف ماذا تحمل معها اللّحظات القادمة لهذا قُل دائمًا: اللهم تولّني فيمن توليت ❤️"
26
375
1K
💯
The person you will be in 5 years depends on: • the food you eat • amount of exercise you do • how much sleep per day • books or articles you read • how much more you write • money you save and invest • who you work with • friends you spend time with • new skills you
0
0
2
We judge people too much by their fleeting opinions—and too little by their consistent actions. Anyone you meet is likely to hold some views you dislike. No one is as bad as their worst idea, and no belief is set in stone. The true test of character is how people treat others.
93
613
2K
Be humble and kind. You may be wrong. Be honest. Character is a door opener. Be forgiving. You will also make mistakes. Be on time. Good manners attracts. Be helpful. We could all use more help. Be happy. Being in a good mood matters. Be generous. Givers sleep better at night. Be
2
18
61
" الانسان الملوث داخلياً لا يستوعب وجود بشرٍ أنقياء"، و الانسان الحقود لا يستوعب وجود بشرٍ طيبين.
1
10
61
Are you incorporating MDT for oligometastatic prostate cancer❓ ✅Here's a brief recap of key trials for #UromigosLive, including ongoing RCT's: METANOVA, TERPS, PROMETHEAN, and KNIGHTS. Please share and comment! #ProstateCancer
The UromigosLive 2025 meeting presents #UromigosShorts videos on GU Oncology topics. The videos with the most views win a prize at #UromigosLive November 7-8th in Nashville, TN. Below, Dr. Omar Mian discusses: Metastasis-directed Therapy in Prostate Cancer.
1
18
52
The UromigosLive 2025 meeting presents #UromigosShorts videos on GU Oncology topics. The videos with the most views win a prize at #UromigosLive November 7-8th in Nashville, TN. Below, Dr. Omar Mian discusses: Metastasis-directed Therapy in Prostate Cancer.
0
16
28
Orange isn’t just a color; it’s a warning sign. Redness, swelling, and skin that looks like an orange peel can all point to IBC. Knowing these symptoms could mean the difference between a delayed diagnosis and timely treatment. https://t.co/3AA9mYOPcV
#breastcancer
1
2
2
👇🏻👇🏻👇🏻
Now that you're educated about IBC, we request that you share these facts and become a donor to improve the landscape of IBC forever. The IBC Network Foundation is a charity, #fundingresearch as fast as we can. Please #donate at https://t.co/yqeri0zlSX
#breastcancerawarenessmonth
0
1
4
Proud of our PGY-5s for presenting our work at the 3rd @KHCFKHCC research conference: 1)Beyond BRCA: Shedding Light on Radiation Outcomes 2)DIBH in the Treatment of Rt Breast Cancer with RNI-prospective study. Mentoring such talented residents is truly rewarding!
0
0
4